000 01901cam  2200325zi 4500
0019.926737
003CaOODSP
00520231115150315
006m     o  d f      
007cr cn|||||||||
008230830t20232023onc     ob   f000 0 eng d
020 |a9780660677316
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP5-162/2023E-PDF
24500|aSummary of National Advisory Committee on Immunization (NACI) Canadian communicable disease report (CCDR) update of September 25, 2023 : |ba NACI update on invasive meningococcal disease (IMD) epidemiology and program-relevant considerations for preventing IMD in individuals at high risk of exposure.
264 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2023.
264 4|c©2023
300 |a1 online resource (4 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Résumé de la mise a jour du Comité consultatif national de l'immunisation (CCNI) dans le relevé des maladies transmissibles au Canada (RMTC) du 25 septembre 2023.
504 |aIncludes bibliographical references.
650 0|aMeningococcal infections|xVaccination|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tRésumé de la mise a jour du Comité consultatif national de l'immunisation (CCNI) dans le relevé des maladies transmissibles au Canada (RMTC) du 25 septembre 2023 : |w(CaOODSP)9.926739
85640|qPDF|s435 KB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP5-162-2023-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-summary-updates-invasive-meningococcal-disease-ccdr.html